These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 140200)

  • 21. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demonstration of a functionally active tPA-like plasminogen activator in human platelets.
    Wang DL; Pan YT; Wang JJ; Cheng CH; Liu CY
    Thromb Haemost; 1994 Apr; 71(4):493-8. PubMed ID: 8052969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urokinase-like plasminogen activator increased in plasma after alcohol drinking.
    Sumi H; Hamada H; Tsushima H; Mihara H
    Alcohol Alcohol; 1988; 23(1):33-43. PubMed ID: 3128990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activation in diabetes mellitus: normalization of blood sugar levels improves impaired enzyme kinetics in vitro.
    Geiger M; Binder BR
    Thromb Haemost; 1985 Aug; 54(2):413-4. PubMed ID: 2934857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Postmortem fibrinolysis and its biological characteristics].
    Bratchik AM
    Probl Gematol Pereliv Krovi; 1975 Jun; 20(6):18-22. PubMed ID: 124429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential.
    Onundarson PT; Francis CW; Marder VJ
    J Lab Clin Med; 1992 Jul; 120(1):120-8. PubMed ID: 1613318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of action of fibrinolytic enzymes in vivo.
    Ambrus JL; Weber FJ; Ambrus CM
    J Med; 1979; 10(1-2):99-119. PubMed ID: 158624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ; Dooijewaard G; Turion PN
    Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.
    Kaplan AP; Austen KF
    J Exp Med; 1972 Dec; 136(6):1378-93. PubMed ID: 4264575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.
    Kaplan AP; Goetzl EJ; Austen KF
    J Clin Invest; 1973 Oct; 52(10):2591-5. PubMed ID: 4729052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dextran-induced lowering of plasminogen proactivator and functionally active high molecular weight kininogen in the rat.
    Berstad J; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1982 May; 50(5):342-9. PubMed ID: 6180597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Purification of the vascular plasminogen activator].
    Angles-Cano E; Sultan Y; Bernard J
    C R Seances Acad Sci D; 1979 Sep; 289(5):485-7. PubMed ID: 117941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assay of prekallikrein as plasminogen proactivator in plasma specimens from reactors to dextran or to contrast media.
    Briseid K; Johansen HT
    Int J Tissue React; 1984; 6(6):529-36. PubMed ID: 6085073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen activator release during venous stasis and exercise as determined by a new specific assay.
    Wiman B; Mellbring G; Rånby M
    Clin Chim Acta; 1983 Jan; 127(2):279-88. PubMed ID: 6218942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A colorimetric assay for releasable plasminogen activator.
    Campbell EE; Shifman MA; Lewis JG; Pasqua JJ; Pizzo SV
    Clin Chem; 1982 May; 28(5):1125-8. PubMed ID: 6210467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radial caseinolysis in agarose: a simple method for detection of plasminogen activator in the presence of inhibitory substances and serum.
    Saksela O
    Anal Biochem; 1981 Mar; 111(2):276-82. PubMed ID: 7195660
    [No Abstract]   [Full Text] [Related]  

  • 40. Differentiation of proactivator from tissue plasminogen activator with low molecular weight in the paranasal mucous membrane.
    Kosugi T; Takagi I; Ariga Y; Kinjo K; Matayoshi S; Noda Y
    Auris Nasus Larynx; 1982; 9(2):99-104. PubMed ID: 6891585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.